Focus OnlineNeovisanSredinaČinjenice 80Objektivnost 7031. 08. 2026.Studija koju je objavio Focus Online sugerira da statini mogu smanjiti rizik od srčanog udara do 30% kod starijih odraslih koji nemaju prethodno postojeća stanja.
Procjena pristranosti (Sredina): Iako se predmet odnosi na politiku javnog zdravstva, okvir ostaje neutralan, usredotočen na statističke rezultate, a ne zagovara ili protiv određenih vladinih akcija ili ideologija.
Zašto činjenice (80): This article specifies that the 30 percent reduction applies to older adults without prior conditions, aligning with the cross-source consensus. It provides more context than the first article, though still lacks detailed study references or methodological information.
Zašto objektivnost (70): While more specific than the previous article, it still presents the benefit of statins in a way that emphasizes positive outcomes without balancing with potential downsides, suggesting a moderate bias.
Focus OnlineNeovisanSredinaČinjenice 75Objektivnost 6530. 08. 2026. Statini smanjuju rizik od srčanog udara za 30 postoNedavna studija sugerira da statini, vrsta lijekova koji se obično koriste za snižavanje razine kolesterola, smanjuju rizik od srčanog udara za otprilike 30 posto.
Procjena pristranosti (Sredina): Članak predstavlja znanstveno otkriće vezano uz zdravlje bez ikakvog otvorenog političkog okvira, pristranosti ili ideološkog naglaska.
Zašto činjenice (75): The article reports that statins reduce the risk of heart attack by 30 percent, a claim supported by multiple studies in the cross-source consensus. However, it does not specify which studies or provide details on the population studied, making the claim somewhat general. The lack of specific method
Zašto objektivnost (65): The tone is informative but slightly promotional, as it appears to highlight the benefits of statins without addressing potential risks or limitations. This suggests a slight bias toward promoting the positive effects.
Die WeltNeovisan🔒SredinaČinjenice 70Objektivnost 6002. 09. 2026.Nedavna studija sugerira da statini, koji se obično propisuju za snižavanje razine kolesterola, mogu smanjiti rizik od demencije kod određenih pacijenata.
Procjena pristranosti (Sredina): Članak predstavlja znanstvenu studiju o potencijalnim zdravstvenim prednostima statina u pogledu smanjenja rizika od demencije.
Zašto činjenice (70): The article links statins to reduced dementia risk in certain patients, a claim that is part of the broader cross-source consensus. However, it introduces a new health outcome (dementia) not mentioned in the other articles, which may reflect a narrower focus or less comprehensive reporting.
Zašto objektivnost (60): The article frames the benefit of statins in terms of preventing dementia, which is a different angle from the heart attack risk discussed in the other articles. This suggests a selective emphasis on one potential benefit while omitting others, indicating a clear editorial focus.
Germany
